Trial NCT03014297

View at ClinicalTrials.gov 
Org. Study IDs: MCC-16-GI-99-PMC

Last trial update was posted on 2019-08-08

MeSH Interventions

Everolimus Fosbretabulin

MeSH Conditions

Neuroendocrine Tumors

Other Conditions

Everolimus

Stopping Reasons

Part I completed. Part 2 will not be done due to sponsor decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID